ShockWave Medical, Inc. (NASDAQ: SWAV) Stock Competitors & Peer Comparison
See SWAV's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SWAV and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SWAV | $334.75 | -0.02% | 12.6B | 78.76 | $4.25 | N/A |
| ABT | $111.27 | +0.32% | 192.6B | 21.36 | $5.21 | +2.23% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| SYK | $341.09 | -1.76% | 130.8B | 25.47 | $13.39 | +1.02% |
| MDT | $90.58 | -0.20% | 116B | 16.38 | $5.53 | +3.14% |
| BSX | $51.69 | +0.53% | 76.9B | 16.68 | $3.10 | N/A |
| EW | $92.56 | -0.53% | 53.3B | 34.29 | $2.70 | N/A |
| DXCM | $91.48 | +0.75% | 34.5B | 39.26 | $2.33 | N/A |
| RMD | $226.74 | +0.33% | 32.9B | 21.06 | $10.77 | +1.05% |
| PHG | $27.38 | +2.16% | 26.8B | 15.64 | $1.75 | +3.62% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
SWAV vs ABT Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, ABT has a market cap of 192.6B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while ABT trades at $111.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas ABT's P/E ratio is 21.36. In terms of profitability, SWAV's ROE is +0.25%, compared to ABT's ROE of +0.11%. Regarding short-term risk, SWAV is less volatile compared to ABT. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
SWAV vs BSX-PA Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, SWAV's ROE is +0.25%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, SWAV is less volatile compared to BSX-PA. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check BSX-PA's competition here
Stryker Corporation (NYSE: SYK)
SWAV vs SYK Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, SYK has a market cap of 130.8B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while SYK trades at $341.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas SYK's P/E ratio is 25.47. In terms of profitability, SWAV's ROE is +0.25%, compared to SYK's ROE of +0.16%. Regarding short-term risk, SWAV is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check SYK's competition here
Medtronic plc (NYSE: MDT)
SWAV vs MDT Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, MDT has a market cap of 116B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while MDT trades at $90.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas MDT's P/E ratio is 16.38. In terms of profitability, SWAV's ROE is +0.25%, compared to MDT's ROE of +0.10%. Regarding short-term risk, SWAV is less volatile compared to MDT. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
SWAV vs BSX Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, BSX has a market cap of 76.9B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while BSX trades at $51.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas BSX's P/E ratio is 16.68. In terms of profitability, SWAV's ROE is +0.25%, compared to BSX's ROE of +0.15%. Regarding short-term risk, SWAV is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
SWAV vs EW Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, EW has a market cap of 53.3B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while EW trades at $92.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas EW's P/E ratio is 34.29. In terms of profitability, SWAV's ROE is +0.25%, compared to EW's ROE of +0.10%. Regarding short-term risk, SWAV is less volatile compared to EW. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
SWAV vs DXCM Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, DXCM has a market cap of 34.5B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while DXCM trades at $91.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas DXCM's P/E ratio is 39.26. In terms of profitability, SWAV's ROE is +0.25%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, SWAV is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check DXCM's competition here
ResMed Inc. (NYSE: RMD)
SWAV vs RMD Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, RMD has a market cap of 32.9B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while RMD trades at $226.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas RMD's P/E ratio is 21.06. In terms of profitability, SWAV's ROE is +0.25%, compared to RMD's ROE of +0.24%. Regarding short-term risk, SWAV is less volatile compared to RMD. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check RMD's competition here
Koninklijke Philips N.V. (NYSE: PHG)
SWAV vs PHG Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, PHG has a market cap of 26.8B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while PHG trades at $27.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas PHG's P/E ratio is 15.64. In terms of profitability, SWAV's ROE is +0.25%, compared to PHG's ROE of +0.10%. Regarding short-term risk, SWAV is less volatile compared to PHG. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
SWAV vs ZBH Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, ZBH has a market cap of 19.3B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while ZBH trades at $99.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas ZBH's P/E ratio is 11.74. In terms of profitability, SWAV's ROE is +0.25%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, SWAV is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
SWAV vs ABMD Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas ABMD's P/E ratio is 65.36. In terms of profitability, SWAV's ROE is +0.25%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, SWAV is less volatile compared to ABMD. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
SWAV vs PEN Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, PEN has a market cap of 12.9B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while PEN trades at $326.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas PEN's P/E ratio is 85.36. In terms of profitability, SWAV's ROE is +0.25%, compared to PEN's ROE of +0.11%. Regarding short-term risk, SWAV is less volatile compared to PEN. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check PEN's competition here
Smith & Nephew plc (NYSE: SNN)
SWAV vs SNN Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, SNN has a market cap of 12.7B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while SNN trades at $30.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas SNN's P/E ratio is 14.17. In terms of profitability, SWAV's ROE is +0.25%, compared to SNN's ROE of +0.12%. Regarding short-term risk, SWAV is less volatile compared to SNN. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
SWAV vs ALGN Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, ALGN has a market cap of 12.6B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while ALGN trades at $176.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas ALGN's P/E ratio is 16.06. In terms of profitability, SWAV's ROE is +0.25%, compared to ALGN's ROE of +0.14%. Regarding short-term risk, SWAV is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check ALGN's competition here
Globus Medical, Inc. (NYSE: GMED)
SWAV vs GMED Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, GMED has a market cap of 11.6B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while GMED trades at $85.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas GMED's P/E ratio is 19.36. In terms of profitability, SWAV's ROE is +0.25%, compared to GMED's ROE of +0.12%. Regarding short-term risk, SWAV is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check GMED's competition here
Glaukos Corporation (NYSE: GKOS)
SWAV vs GKOS Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, GKOS has a market cap of 11.2B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while GKOS trades at $189.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas GKOS's P/E ratio is -220.30. In terms of profitability, SWAV's ROE is +0.25%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, SWAV is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check GKOS's competition here
Insulet Corp. (NASDAQ: PODD)
SWAV vs PODD Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, PODD has a market cap of 10.1B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while PODD trades at $146.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas PODD's P/E ratio is 24.95. In terms of profitability, SWAV's ROE is +0.25%, compared to PODD's ROE of +0.27%. Regarding short-term risk, SWAV is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
SWAV vs BIO Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, BIO has a market cap of 9.7B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while BIO trades at $361.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas BIO's P/E ratio is 38.93. In terms of profitability, SWAV's ROE is +0.25%, compared to BIO's ROE of +0.03%. Regarding short-term risk, SWAV is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check BIO's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
SWAV vs BIO-B Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, BIO-B has a market cap of 9.5B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while BIO-B trades at $348.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas BIO-B's P/E ratio is 103.33. In terms of profitability, SWAV's ROE is +0.25%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, SWAV is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for SWAV.Check BIO-B's competition here
Masimo Corporation (NASDAQ: MASI)
SWAV vs MASI Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas MASI's P/E ratio is 44.43. In terms of profitability, SWAV's ROE is +0.25%, compared to MASI's ROE of +0.09%. Regarding short-term risk, SWAV is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for SWAV.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
SWAV vs BRKR Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, BRKR has a market cap of 8.8B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while BRKR trades at $57.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas BRKR's P/E ratio is 29.11. In terms of profitability, SWAV's ROE is +0.25%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, SWAV is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check BRKR's competition here
Inari Medical, Inc. (NASDAQ: NARI)
SWAV vs NARI Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas NARI's P/E ratio is -59.24. In terms of profitability, SWAV's ROE is +0.25%, compared to NARI's ROE of -0.00%. Regarding short-term risk, SWAV is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for SWAV.Check NARI's competition here
LivaNova PLC (NASDAQ: LIVN)
SWAV vs LIVN Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, LIVN has a market cap of 4.4B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while LIVN trades at $82.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas LIVN's P/E ratio is 19.19. In terms of profitability, SWAV's ROE is +0.25%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, SWAV is less volatile compared to LIVN. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
SWAV vs ITGR Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, ITGR has a market cap of 4.2B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while ITGR trades at $125.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas ITGR's P/E ratio is 19.69. In terms of profitability, SWAV's ROE is +0.25%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, SWAV is less volatile compared to ITGR. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check ITGR's competition here
Haemonetics Corporation (NYSE: HAE)
SWAV vs HAE Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, HAE has a market cap of 4.1B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while HAE trades at $90.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas HAE's P/E ratio is 18.06. In terms of profitability, SWAV's ROE is +0.25%, compared to HAE's ROE of +0.11%. Regarding short-term risk, SWAV is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check HAE's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
SWAV vs IRTC Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, IRTC has a market cap of 4B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while IRTC trades at $123.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas IRTC's P/E ratio is -192.44. In terms of profitability, SWAV's ROE is +0.25%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, SWAV is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
SWAV vs AXNX Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas AXNX's P/E ratio is -709.80. In terms of profitability, SWAV's ROE is +0.25%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, SWAV is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for SWAV.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
SWAV vs TMDX Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, TMDX has a market cap of 3.1B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while TMDX trades at $89.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas TMDX's P/E ratio is 45.50. In terms of profitability, SWAV's ROE is +0.25%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, SWAV is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
SWAV vs AXGN Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, AXGN has a market cap of 2.6B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while AXGN trades at $48.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas AXGN's P/E ratio is 126.45. In terms of profitability, SWAV's ROE is +0.25%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, SWAV is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
SWAV vs UFPT Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, UFPT has a market cap of 2.5B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while UFPT trades at $319.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas UFPT's P/E ratio is 32.67. In terms of profitability, SWAV's ROE is +0.25%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, SWAV is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check UFPT's competition here
Butterfly Network, Inc. (NYSE: BFLY)
SWAV vs BFLY Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, BFLY has a market cap of 2.4B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while BFLY trades at $8.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas BFLY's P/E ratio is -36.79. In terms of profitability, SWAV's ROE is +0.25%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, SWAV is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check BFLY's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
SWAV vs ESTA Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, ESTA has a market cap of 2.2B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while ESTA trades at $75.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas ESTA's P/E ratio is -59.99. In terms of profitability, SWAV's ROE is +0.25%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, SWAV is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check ESTA's competition here
NuVasive, Inc. (NASDAQ: NUVA)
SWAV vs NUVA Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas NUVA's P/E ratio is 75.00. In terms of profitability, SWAV's ROE is +0.25%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, SWAV is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
SWAV vs NVCR Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, NVCR has a market cap of 2B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while NVCR trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas NVCR's P/E ratio is -11.36. In terms of profitability, SWAV's ROE is +0.25%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, SWAV is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check NVCR's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
SWAV vs INSP Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, INSP has a market cap of 1.7B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while INSP trades at $58.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas INSP's P/E ratio is 25.62. In terms of profitability, SWAV's ROE is +0.25%, compared to INSP's ROE of +0.18%. Regarding short-term risk, SWAV is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check INSP's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
SWAV vs TNDM Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, TNDM has a market cap of 1.6B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while TNDM trades at $23.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas TNDM's P/E ratio is -21.03. In terms of profitability, SWAV's ROE is +0.25%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, SWAV is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check TNDM's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
SWAV vs ATEC Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, ATEC has a market cap of 1.5B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while ATEC trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas ATEC's P/E ratio is -162.50. In terms of profitability, SWAV's ROE is +0.25%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, SWAV is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check ATEC's competition here
CONMED Corporation (NYSE: CNMD)
SWAV vs CNMD Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while CNMD trades at $49.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas CNMD's P/E ratio is 10.94. In terms of profitability, SWAV's ROE is +0.25%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, SWAV is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check CNMD's competition here
Enovis Corporation (NYSE: ENOV)
SWAV vs ENOV Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, ENOV has a market cap of 1.5B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while ENOV trades at $25.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas ENOV's P/E ratio is 7.36. In terms of profitability, SWAV's ROE is +0.25%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, SWAV is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check ENOV's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
SWAV vs IART Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, IART has a market cap of 1.4B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while IART trades at $18.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas IART's P/E ratio is 7.73. In terms of profitability, SWAV's ROE is +0.25%, compared to IART's ROE of -0.01%. Regarding short-term risk, SWAV is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check IART's competition here
Artivion, Inc. (NYSE: AORT)
SWAV vs AORT Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, AORT has a market cap of 1.4B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while AORT trades at $28.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas AORT's P/E ratio is 47.38. In terms of profitability, SWAV's ROE is +0.25%, compared to AORT's ROE of -0.01%. Regarding short-term risk, SWAV is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check AORT's competition here
Heska Corporation (NASDAQ: HSKA)
SWAV vs HSKA Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas HSKA's P/E ratio is -62.49. In terms of profitability, SWAV's ROE is +0.25%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, SWAV is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for SWAV.Check HSKA's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
SWAV vs PRCT Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while PRCT trades at $21.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas PRCT's P/E ratio is -11.31. In terms of profitability, SWAV's ROE is +0.25%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, SWAV is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check PRCT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
SWAV vs AVNS Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas AVNS's P/E ratio is 27.77. In terms of profitability, SWAV's ROE is +0.25%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, SWAV is less volatile compared to AVNS. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check AVNS's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
SWAV vs LMRI Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while LMRI trades at $12.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas LMRI's P/E ratio is -22.82. In terms of profitability, SWAV's ROE is +0.25%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, SWAV is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check LMRI's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
SWAV vs SILK Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas SILK's P/E ratio is -18.96. In terms of profitability, SWAV's ROE is +0.25%, compared to SILK's ROE of -0.35%. Regarding short-term risk, SWAV is similarly volatile compared to SILK. This indicates similar risk in terms of short-term price fluctuations for SWAV.Check SILK's competition here
IRadimed Corporation (NASDAQ: IRMD)
SWAV vs IRMD Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while IRMD trades at $87.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas IRMD's P/E ratio is 43.80. In terms of profitability, SWAV's ROE is +0.25%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, SWAV is less volatile compared to IRMD. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
SWAV vs FNA Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas FNA's P/E ratio is -19.83. In terms of profitability, SWAV's ROE is +0.25%, compared to FNA's ROE of -0.35%. Regarding short-term risk, SWAV is less volatile compared to FNA. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
SWAV vs BVS Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, BVS has a market cap of 941M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while BVS trades at $13.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas BVS's P/E ratio is 18.28. In terms of profitability, SWAV's ROE is +0.25%, compared to BVS's ROE of +0.28%. Regarding short-term risk, SWAV is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
SWAV vs CBLL Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, CBLL has a market cap of 882.2M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while CBLL trades at $23.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas CBLL's P/E ratio is -14.26. In terms of profitability, SWAV's ROE is +0.25%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, SWAV is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check CBLL's competition here
InMode Ltd. (NASDAQ: INMD)
SWAV vs INMD Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, INMD has a market cap of 873.7M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while INMD trades at $15.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas INMD's P/E ratio is 10.56. In terms of profitability, SWAV's ROE is +0.25%, compared to INMD's ROE of +0.12%. Regarding short-term risk, SWAV is less volatile compared to INMD. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check INMD's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
SWAV vs AVR Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, AVR has a market cap of 868.3M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while AVR trades at $8.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas AVR's P/E ratio is -4.00. In terms of profitability, SWAV's ROE is +0.25%, compared to AVR's ROE of -0.78%. Regarding short-term risk, SWAV is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check AVR's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
SWAV vs CSII Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas CSII's P/E ratio is -20.83. In terms of profitability, SWAV's ROE is +0.25%, compared to CSII's ROE of -0.14%. Regarding short-term risk, SWAV is less volatile compared to CSII. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
SWAV vs SIBN Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, SIBN has a market cap of 840.4M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while SIBN trades at $18.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas SIBN's P/E ratio is -55.74. In terms of profitability, SWAV's ROE is +0.25%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, SWAV is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check SIBN's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
SWAV vs BBNX Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, BBNX has a market cap of 813.4M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while BBNX trades at $18.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas BBNX's P/E ratio is -11.97. In terms of profitability, SWAV's ROE is +0.25%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, SWAV is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check BBNX's competition here
Varex Imaging Corporation (NASDAQ: VREX)
SWAV vs VREX Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, VREX has a market cap of 778.9M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while VREX trades at $18.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas VREX's P/E ratio is 19.47. In terms of profitability, SWAV's ROE is +0.25%, compared to VREX's ROE of +0.05%. Regarding short-term risk, SWAV is less volatile compared to VREX. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check VREX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
SWAV vs AHCO Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, AHCO has a market cap of 775.5M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while AHCO trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas AHCO's P/E ratio is 11.63. In terms of profitability, SWAV's ROE is +0.25%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, SWAV is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check AHCO's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
SWAV vs SSII Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, SSII has a market cap of 766.5M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while SSII trades at $3.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas SSII's P/E ratio is -74.70. In terms of profitability, SWAV's ROE is +0.25%, compared to SSII's ROE of -0.27%. Regarding short-term risk, SWAV is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check SSII's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
SWAV vs BWAY Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, BWAY has a market cap of 646M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while BWAY trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas BWAY's P/E ratio is 41.84. In terms of profitability, SWAV's ROE is +0.25%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, SWAV is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check BWAY's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
SWAV vs KIDS Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, KIDS has a market cap of 642.4M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while KIDS trades at $25.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas KIDS's P/E ratio is -21.19. In terms of profitability, SWAV's ROE is +0.25%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, SWAV is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check KIDS's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
SWAV vs CTKB Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, CTKB has a market cap of 631.5M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while CTKB trades at $4.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas CTKB's P/E ratio is -25.91. In terms of profitability, SWAV's ROE is +0.25%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, SWAV is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check CTKB's competition here
Surmodics, Inc. (NASDAQ: SRDX)
SWAV vs SRDX Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas SRDX's P/E ratio is -34.66. In terms of profitability, SWAV's ROE is +0.25%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, SWAV is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for SWAV.Check SRDX's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
SWAV vs DCTH Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, DCTH has a market cap of 599.3M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while DCTH trades at $17.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas DCTH's P/E ratio is 1736.00. In terms of profitability, SWAV's ROE is +0.25%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, SWAV is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check DCTH's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
SWAV vs APEN Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas APEN's P/E ratio is -9.43. In terms of profitability, SWAV's ROE is +0.25%, compared to APEN's ROE of -0.85%. Regarding short-term risk, SWAV is less volatile compared to APEN. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check APEN's competition here
Cerus Corporation (NASDAQ: CERS)
SWAV vs CERS Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, CERS has a market cap of 572.3M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while CERS trades at $2.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas CERS's P/E ratio is -56.69. In terms of profitability, SWAV's ROE is +0.25%, compared to CERS's ROE of -0.10%. Regarding short-term risk, SWAV is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check CERS's competition here
ZimVie Inc. (NASDAQ: ZIMV)
SWAV vs ZIMV Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, SWAV's ROE is +0.25%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, SWAV is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for SWAV.Check ZIMV's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
SWAV vs TCMD Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, TCMD has a market cap of 534.8M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while TCMD trades at $23.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas TCMD's P/E ratio is 26.94. In terms of profitability, SWAV's ROE is +0.25%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, SWAV is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check TCMD's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
SWAV vs NPCE Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, NPCE has a market cap of 494.7M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while NPCE trades at $14.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas NPCE's P/E ratio is -22.32. In terms of profitability, SWAV's ROE is +0.25%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, SWAV is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check NPCE's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
SWAV vs CLPT Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, CLPT has a market cap of 462.4M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while CLPT trades at $15.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas CLPT's P/E ratio is -13.07. In terms of profitability, SWAV's ROE is +0.25%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, SWAV is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check CLPT's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
SWAV vs SGHT Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, SGHT has a market cap of 452.7M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while SGHT trades at $8.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas SGHT's P/E ratio is -14.86. In terms of profitability, SWAV's ROE is +0.25%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, SWAV is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check SGHT's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
SWAV vs OFIX Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, OFIX has a market cap of 411.5M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while OFIX trades at $10.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas OFIX's P/E ratio is -13.30. In terms of profitability, SWAV's ROE is +0.25%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, SWAV is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check OFIX's competition here
Carlsmed, Inc. (NASDAQ: CARL)
SWAV vs CARL Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, CARL has a market cap of 380.3M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while CARL trades at $13.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas CARL's P/E ratio is -9.78. In terms of profitability, SWAV's ROE is +0.25%, compared to CARL's ROE of -0.38%. Regarding short-term risk, SWAV is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check CARL's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
SWAV vs PACB Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, PACB has a market cap of 357.2M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while PACB trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas PACB's P/E ratio is -2.80. In terms of profitability, SWAV's ROE is +0.25%, compared to PACB's ROE of -49.62%. Regarding short-term risk, SWAV is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check PACB's competition here
Picard Medical, Inc. (AMEX: PMI)
SWAV vs PMI Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, PMI has a market cap of 354.8M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while PMI trades at $3.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas PMI's P/E ratio is -2.88. In terms of profitability, SWAV's ROE is +0.25%, compared to PMI's ROE of +4.99%. Regarding short-term risk, SWAV is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check PMI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
SWAV vs CATX Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, CATX has a market cap of 352.4M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while CATX trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas CATX's P/E ratio is -2.19. In terms of profitability, SWAV's ROE is +0.25%, compared to CATX's ROE of -0.42%. Regarding short-term risk, SWAV is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check CATX's competition here
Electromed, Inc. (AMEX: ELMD)
SWAV vs ELMD Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, ELMD has a market cap of 351.1M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while ELMD trades at $42.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas ELMD's P/E ratio is 36.24. In terms of profitability, SWAV's ROE is +0.25%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, SWAV is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check ELMD's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
SWAV vs TLSI Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, TLSI has a market cap of 346.7M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while TLSI trades at $5.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas TLSI's P/E ratio is -3.35. In terms of profitability, SWAV's ROE is +0.25%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, SWAV is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check TLSI's competition here
CapsoVision, Inc. (NASDAQ: CV)
SWAV vs CV Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, CV has a market cap of 339.3M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while CV trades at $6.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas CV's P/E ratio is -2.72. In terms of profitability, SWAV's ROE is +0.25%, compared to CV's ROE of +1.27%. Regarding short-term risk, SWAV is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check CV's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
SWAV vs SENS Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, SENS has a market cap of 323.1M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while SENS trades at $7.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas SENS's P/E ratio is -3.86. In terms of profitability, SWAV's ROE is +0.25%, compared to SENS's ROE of -1.66%. Regarding short-term risk, SWAV is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check SENS's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
SWAV vs SMLR Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas SMLR's P/E ratio is 3.92. In terms of profitability, SWAV's ROE is +0.25%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, SWAV is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for SWAV.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
SWAV vs TMCI Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, TMCI has a market cap of 292.6M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while TMCI trades at $4.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas TMCI's P/E ratio is -4.80. In terms of profitability, SWAV's ROE is +0.25%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, SWAV is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check TMCI's competition here
RxSight, Inc. (NASDAQ: RXST)
SWAV vs RXST Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, RXST has a market cap of 290.2M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while RXST trades at $7.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas RXST's P/E ratio is -7.54. In terms of profitability, SWAV's ROE is +0.25%, compared to RXST's ROE of -0.17%. Regarding short-term risk, SWAV is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check RXST's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
SWAV vs ANIK Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, ANIK has a market cap of 283.3M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while ANIK trades at $21.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas ANIK's P/E ratio is 43.20. In terms of profitability, SWAV's ROE is +0.25%, compared to ANIK's ROE of -0.03%. Regarding short-term risk, SWAV is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check ANIK's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
SWAV vs MGRM Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas MGRM's P/E ratio is -12.00. In terms of profitability, SWAV's ROE is +0.25%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, SWAV is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for SWAV.Check MGRM's competition here
Profound Medical Corp. (NASDAQ: PROF)
SWAV vs PROF Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, PROF has a market cap of 242.4M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while PROF trades at $6.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas PROF's P/E ratio is -5.38. In terms of profitability, SWAV's ROE is +0.25%, compared to PROF's ROE of -0.56%. Regarding short-term risk, SWAV is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check PROF's competition here
Nevro Corp. (NYSE: NVRO)
SWAV vs NVRO Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas NVRO's P/E ratio is -1.91. In terms of profitability, SWAV's ROE is +0.25%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, SWAV is less volatile compared to NVRO. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check NVRO's competition here
Neuronetics, Inc. (NASDAQ: STIM)
SWAV vs STIM Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, STIM has a market cap of 210.9M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while STIM trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas STIM's P/E ratio is -5.61. In terms of profitability, SWAV's ROE is +0.25%, compared to STIM's ROE of -1.51%. Regarding short-term risk, SWAV is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check STIM's competition here
Avita Medical Inc. (NASDAQ: RCEL)
SWAV vs RCEL Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, RCEL has a market cap of 199M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while RCEL trades at $8.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas RCEL's P/E ratio is -5.10. In terms of profitability, SWAV's ROE is +0.25%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, SWAV is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check RCEL's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
SWAV vs BSGM Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas BSGM's P/E ratio is -5.81. In terms of profitability, SWAV's ROE is +0.25%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, SWAV is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check BSGM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
SWAV vs LUCD Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, LUCD has a market cap of 184.1M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while LUCD trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas LUCD's P/E ratio is -2.61. In terms of profitability, SWAV's ROE is +0.25%, compared to LUCD's ROE of -0.02%. Regarding short-term risk, SWAV is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check LUCD's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
SWAV vs MDGS Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas MDGS's P/E ratio is -0.27. In terms of profitability, SWAV's ROE is +0.25%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, SWAV is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check MDGS's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
SWAV vs FOCL Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, FOCL has a market cap of 178M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while FOCL trades at $4.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas FOCL's P/E ratio is -5.80. In terms of profitability, SWAV's ROE is +0.25%, compared to FOCL's ROE of -1.38%. Regarding short-term risk, SWAV is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check FOCL's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
SWAV vs QIPT Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas QIPT's P/E ratio is -15.87. In terms of profitability, SWAV's ROE is +0.25%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, SWAV is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for SWAV.Check QIPT's competition here
Inogen, Inc. (NASDAQ: INGN)
SWAV vs INGN Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, INGN has a market cap of 157.3M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while INGN trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas INGN's P/E ratio is -6.38. In terms of profitability, SWAV's ROE is +0.25%, compared to INGN's ROE of -0.13%. Regarding short-term risk, SWAV is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
SWAV vs QTRX Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, QTRX has a market cap of 134.7M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while QTRX trades at $2.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas QTRX's P/E ratio is -1.79. In terms of profitability, SWAV's ROE is +0.25%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, SWAV is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check QTRX's competition here
Owlet, Inc. (NYSE: OWLT)
SWAV vs OWLT Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, OWLT has a market cap of 114.5M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while OWLT trades at $6.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas OWLT's P/E ratio is -45.21. In terms of profitability, SWAV's ROE is +0.25%, compared to OWLT's ROE of -0.50%. Regarding short-term risk, SWAV is less volatile compared to OWLT. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check OWLT's competition here
iCAD, Inc. (NASDAQ: ICAD)
SWAV vs ICAD Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas ICAD's P/E ratio is -20.37. In terms of profitability, SWAV's ROE is +0.25%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, SWAV is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for SWAV.Check ICAD's competition here
Solana Company (NASDAQ: HSDT)
SWAV vs HSDT Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, HSDT has a market cap of 105.1M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while HSDT trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas HSDT's P/E ratio is -0.02. In terms of profitability, SWAV's ROE is +0.25%, compared to HSDT's ROE of -1.55%. Regarding short-term risk, SWAV is less volatile compared to HSDT. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check HSDT's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
SWAV vs HJLI Comparison August 2026
ShockWave Medical, Inc. (NASDAQ: SWAV) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SWAV stands at 12.6B. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, SWAV is priced at $334.75 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SWAV currently has a P/E ratio of 78.76, whereas HJLI's P/E ratio is N/A. In terms of profitability, SWAV's ROE is +0.25%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, SWAV is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for SWAV.Check HJLI's competition here